-transparent.png){kind=logo}
In vitro immune function was assessed in patients with multiple sclerosis (MS) who were receiving Imuran therapy, in untreated MS patients, and in controls. In untreated stable MS patients, concanavalin A (Con A)-driven mitogenic reactivity (T effector function) and Con A-induced suppressor activity were modestly reduced compared to controls; pokeweed mitogen-induced immunoglobulin G (IgG) secretion was increased. Untreated patients with active MS demonstrated high levels of IgG secretion and marked decreases in suppressor activity. In Imuran-treated patients, Con A mitogenic responses and suppressor activity were comparable to those observed in untreated stable patients, and IgG secretion was reduced. The results in the treated patients likely reflect a direct effect of Imuran on B cell function rather than an indirect effect mediated via suppressor cells.
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
January 1974,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
January 1971,
Acta neurologica Scandinavica,
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
January 1969,
Henry Ford Hospital medical journal,
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
November 1965,
Archives of ophthalmology (Chicago, Ill. : 1960),
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
September 1975,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
February 1967,
American journal of obstetrics and gynecology,
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
March 1973,
Helvetica chirurgica acta,
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
July 1966,
Annals of allergy,
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
May 1965,
The Journal of pediatrics,
J J Oger, and
J P Antel, and
H H Kuo, and
B G Arnason
August 2008,
Mini reviews in medicinal chemistry,
